Berlin, Germany

Roland Kühne

This inventor holds 1 USPTO granted patent. Top assignee: Zentaris Ag. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roland Kühne. Retrieved from https://idiyas.com/inventor/roland-kanduumlhne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Roland Kühne

Introduction

Roland Kühne is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that interact with hormonal systems. His work has implications for various medical applications.

Latest Patents

Kühne holds a patent for "Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone." This innovative patent showcases his expertise in creating chemical compounds that can potentially influence hormonal activity, which is crucial for various therapeutic interventions.

Career Highlights

Kühne is associated with Zentaris AG, a company that focuses on developing innovative therapies in the field of endocrinology and oncology. His role at Zentaris AG has allowed him to contribute to groundbreaking research and development efforts in the pharmaceutical industry.

Collaborations

Throughout his career, Kühne has collaborated with esteemed colleagues such as Peter Strehlke and Peter Droescher. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of effective medical solutions.

Conclusion

Roland Kühne's contributions to the field of pharmaceuticals through his patent and work at Zentaris AG highlight his role as an influential inventor. His innovative approaches continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…